Lek is a Small Player in Big Game, Dnevnik Suggests
Ljubljana, 5 September - The intent of the Swiss pharmaceutical Novartis to takeover Slovenian drug-maker Lek is only part of the game in which Lek is involved. This small player is in fact participating in a much bigger game that has been rather neglected, one where moves are being dictated by both sides of the Atlantic, observes Wednesday's edition of the daily Dnevnik.
The rest of this news item is available to subscribers.
The news item consists of 1.765 characters (without spaces) or 339 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.